Antibacterial Agents TRIZ Cases

Carbonyldiimidazole catalyzes coupling of benzoxazole and oxadiazole fragments, creating potent antimicrobial agents against drug-resistant strains.

Thienolate compounds bind metallo-beta-lactamase active sites, blocking hydrolysis and restoring beta-lactam antibiotic efficacy against resistant strains.

A surface composition combining antimicrobial agents with stabilized Bacillus probiotics to reduce pathogenic microorganisms.

A novel protein regulates proteolytic activity, cell invasiveness, and smooth muscle contraction without known motif structures.

Modular diffocin gene clusters enable selective pathogen elimination without harming commensal gut microbiota.

A vancomycin-based topical gel formulation delivers sustained antibiotic potency directly to wound sites.

Antibodies from bovine colostrum neutralize toxins and clear spores, addressing high recurrence rates in Clostridium difficile infections.

Bacteroides ovatus CCFM1021 reduces pro-inflammatory factors and stabilizes intestinal microbiota, avoiding damage from bacterial lysis.

In vitro production of lysis deficient bacteriophages eliminates endotoxin release and immune system response triggered by bacterial cell wall rupture.

Antibacterial proteins degrade bacterial cell walls to treat staphylococcal infections while overcoming antibiotic resistance.

Esc-CHP-1 bacteriophage lyses enterohemorrhagic E. coli without harming beneficial flora, resolving antibiotic resistance trade-offs.

Segmented peptide inhibitors cross cell membranes to block JNK activation, expanding treatment scope beyond limited existing drugs.

Agonist antigen binding proteins activate human LCAT to increase HDL-C plasma levels, addressing low HDL limitations in cardiovascular therapy.

Nicotinamide riboside and urolithin A condition T cells to overcome exhaustion in immunosuppressive tumor microenvironments.

RIVPA peptide mitigates chemotherapy-induced mucositis by converting harmful stress into protective adaptive immune responses without triggering inflammation.

Segmented bacterial strains target distinct T helper pathways, resolving the trade-off between selective precision and broad pathogen defense reliability.

A polymethylmethacrylate bone cement encapsulates amphotericin B within mixed micelles for controlled release.

Endospore-forming Bacillus isolates withstand heat processing to reduce Salmonella and improve poultry production parameters.

Combining Bacillus velezensis with Yarrowia lypolytica suppresses Malassezia biofilm formation to treat scalp disorders.

Injectable pyrrole salt formulation uses cyclodextrin inclusion complexes to enhance solubility and stability for parenteral delivery.

Halo active aromatic sulfonamide compounds treat drug-resistant bacterial, viral, and fungal infections while minimizing caustic effects on human tissues.

Cyclic boronate inhibitors bind beta-lactamases to overcome bacterial resistance and restore antibiotic susceptibility.

Naphthyridin-2(1H)-one derivatives combat multi-drug resistant tuberculosis via composite molecular structures and periodic dosing.

A 2-alkynylmannose derivative inhibits bacterial adhesion by blocking FimH proteins.

Covalent modification of Cysteine 797 enables selective inhibition of the T790M mutant while sparing wild-type EGFR, resolving toxicity constraints.

TBME or DME precipitates esterified compounds at pH 2.5-3.5, eliminating vacuum drying and reducing impurities.

Substituted pyrrole derivatives act as positive allosteric modulators to enhance endogenous acetylcholine transmission.

A silicone-PTFE interpenetrating polymer network dressing restores skin barrier function and manages exudate for burn victims.

Surface cysteine substitutions in TNFSF muteins form disulfide bonds, stabilizing multimers without long linkers that cause immunogenic effects.

Hinge domain engineering of Fc variants alters binding affinity to Fc ligands, resolving suboptimal cytotoxic potency in antibody therapies.

An immunogenic fusion protein vaccine combines detoxified pneumolysin with choline-binding protein A fragments to elicit protective antibodies.

Esterified tizoxanide analogues bypass low intestinal absorption to deliver higher plasma concentrations for treating intracellular infections.

One-pot synthesis using pyridinium hydrogen sulfate catalyst eliminates harmful solvents while producing imidazole derivatives with high antimicrobial efficacy.

Glycolic acid combined with anionic and nonionic surfactants creates a broad-spectrum antimicrobial barrier.

Dual LSD and PKC-θ inhibition alters EMT processes to eliminate resistant cancer stem cells, preventing recurrence.

Cyano-pyrazine derivatives inhibit cysteine proteases through targeted structural modification.

Engineered Listeria vectors target antigen-presenting cells and tumor sites, resolving systemic delivery limitations while enhancing Th1 immune responses.

Inactivated sporulation-deficient Brevibacillus texasporus cells promote animal weight gain and improve feed conversion through preserved antibacterial peptides.

Anhydride preparation via solvent extraction increases doripenem solubility, resolving hydrate instability and purity trade-offs.

Hypochlorite saline oxidizes nucleic acids to clear mucus, reducing antibiotic dependency and pulmonary infections in cystic fibrosis.

Stabilized silver polydiguanide complex delivers potent antibacterial activity through controlled oxidation states.

A cell-free expression system produces bacteriophages using lysates and host-specific factors.

Nuclear transport modifiers block inflammatory signal cascades to prevent organ damage while maintaining bacterial clearance.